Basic information Uses Safety Related Supplier

ChemicalBook Product Catalog Biochemical Engineering Biochemical Reagents Agonist Inhibitors CID 16020046

1/1

CID 16020046 NEW

$33.00 2mg

$56.00 5mg

$81.00 10mg

Min. Order
Purity99.67%
Cas No834903-43-4
Supply Ability10g
Update time2026-04-13

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP6Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	CID 16020046
CAS No	834903-43-4
EC-No
Min. Order
Purity	99.67%
Supply Ability	10g
Release date	2026/04/13

Product Introduction

Bioactivity

Name	CID 16020046
Description	CID 16020046 (C390-0219) is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM in yeast.
In vitro	In yeast cells expressing human GPR55, CID16020046 inhibited agonist-induced receptor activation. In human embryonic kidney (HEK293) cells stably expressing human GPR55, CID16020046 behaved as an antagonist on LPI-mediated Ca2+ release and extracellular signal-regulated kinases activation, but not in HEK293 cells expressing cannabinoid receptor 1 or 2 (CB1 or CB2). CID16020046 dose-dependently inhibited lysophosphatidylinositol (LPI)-induced activation of nuclear factor of activated T-cells (NFAT), nuclear factor κ of activated B cells (NF-κB) and serum response element, translocation of NFAT and NF-κB, and GPR55 internalization [1].
Storage	Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.7 mM), Sonication is recommended. DMSO : 55 mg/mL (129.28 mM), Sonication is recommended.
Keywords	wound \| platelet \| phosphorylation \| m-opioid \| lysophosphatidylinositol \| LPI \| KCNH2 \| Inhibitor \| inhibit \| HMVEC \| hERG \| HEK \| healing \| GPR55 \| G protein-coupled receptor 55 \| function \| ERK1/2 \| endothelial \| CID-16020046 \| CID16020046 \| CID 16020046 \| cells \| CannabinoidReceptor \| Cannabinoid Receptor \| Ca2+ \| acetylcholinesterase
Inhibitors Related	RTICBM-189 \| β-Caryophyllene \| CB2 modulator 1 \| Pregnenolone \| Pregnenolone acetate \| CB1 antagonist 2 \| Dehydroabiethylamine \| CB2 receptor agonist 2 \| AM-1235 \| 2,3-Butanediol \| Drinabant \| AM281
Related Compound Libraries	Anti-Neurodegenerative Disease Compound Library \| Bioactive Compound Library \| Neuronal Signaling Compound Library \| Membrane Protein-targeted Compound Library \| Neurotransmitter Receptor Compound Library \| Inhibitor Library \| NO PAINS Compound Library \| Endocrinology-Hormone Compound Library \| Immunology/Inflammation Compound Library \| Bioactive Compounds Library Max \| GPCR Compound Library \| Anti-Cancer Compound Library

show more

Company Profile Introduction

You may like

Recommended supplier

Send Inquriy